Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthias Holdhoff, MD
Johns Hopkins University
Principal Investigator - Peter Sordillo, MD, PhD
SignPath Pharma
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
Benjamin Levy, MDMatthias Holdhoff, MDMichael J Pishvaian, MD, PhDRachel Alexander, MDSolmaz Sahebjam, MDRecruiting - Johns Hopkins University/johns Hopkins Hospital
Baltimore, Maryland, United States
Carlos Romo, MD, PhDDavid Kamson, MD, PhDJaishri Blakeley, MD, PhDJohn Laterra, MD, PhDKarisa Schreck, MD, PhDKristin Redmond, MD, PhDLawrence Kleinberg, MD, PhDMatthias Holdhoff, MD, PhDStuart Grossman, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Mar 2023
- Primary completion
- 28 Feb 2026
- Completion
- 31 May 2027
- Last update posted
- 29 Nov 2024
- Registered enrollment
- 30
- Registry id
- NCT05768919
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.